These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16389454)

  • 1. Liver X receptors in cardiovascular and metabolic disease.
    Geyeregger R; Zeyda M; Stulnig TM
    Cell Mol Life Sci; 2006 Mar; 63(5):524-39. PubMed ID: 16389454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor signaling pathways in cardiovascular disease.
    Tontonoz P; Mangelsdorf DJ
    Mol Endocrinol; 2003 Jun; 17(6):985-93. PubMed ID: 12690094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.
    Lehrke M; Lebherz C; Millington SC; Guan HP; Millar J; Rader DJ; Wilson JM; Lazar MA
    Cell Metab; 2005 May; 1(5):297-308. PubMed ID: 16054077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.
    Faulds MH; Zhao C; Dahlman-Wright K
    Curr Opin Pharmacol; 2010 Dec; 10(6):692-7. PubMed ID: 20829110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of LXR.
    Michael LF; Schkeryantz JM; Burris TP
    Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXRs: new therapeutic targets in atherosclerosis?
    Joseph SB; Tontonoz P
    Curr Opin Pharmacol; 2003 Apr; 3(2):192-7. PubMed ID: 12681243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.
    Xiao L; Xie X; Zhai Y
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1316-21. PubMed ID: 20659512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
    Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
    Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
    Nomiyama T; Bruemmer D
    Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet dreams for LXR.
    Lazar MA; Willson TM
    Cell Metab; 2007 Mar; 5(3):159-61. PubMed ID: 17339022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis.
    Edwards PA; Kennedy MA; Mak PA
    Vascul Pharmacol; 2002 Apr; 38(4):249-56. PubMed ID: 12449021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages.
    Rébé C; Raveneau M; Chevriaux A; Lakomy D; Sberna AL; Costa A; Bessède G; Athias A; Steinmetz E; Lobaccaro JM; Alves G; Menicacci A; Vachenc S; Solary E; Gambert P; Masson D
    Circ Res; 2009 Aug; 105(4):393-401. PubMed ID: 19628791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists.
    Liang Y; Jiang XC; Liu R; Liang G; Beyer TP; Gao H; Ryan TP; Dan Li S; Eacho PI; Cao G
    Mol Endocrinol; 2004 Aug; 18(8):2000-10. PubMed ID: 15131258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
    Bensinger SJ; Tontonoz P
    Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptors as potential therapeutic targets for multiple diseases.
    Cao G; Liang Y; Jiang XC; Eacho PI
    Drug News Perspect; 2004; 17(1):35-41. PubMed ID: 14993933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke.
    Morales JR; Ballesteros I; Deniz JM; Hurtado O; Vivancos J; Nombela F; Lizasoain I; Castrillo A; Moro MA
    Circulation; 2008 Sep; 118(14):1450-9. PubMed ID: 18794391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.